BioSpace News Archive

Design Therapeutics, a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, today announced the successful completion of a $125 million Series B financing, led by Logos Capital.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it has signed a warrant exercise agreement with an existing institutional investor

SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA).

Ocutrx Technologies, a California-based technology company known for its development pipeline of Oculenz Advanced Macular Degeneration (AMD) patient augmented reality (AR) headset, the ORLenz™ AR surgery headset, and the OR-Bot Surgery Visualization Theatre™, and the Scopetrx™ Wireless Swivel Camera Laparoscopic instrument, has announced the appointment of Dr. William “Bill” Link Ph.D.

January 2021, Thousand Oaks Biopharmaceuticals Group announced that it had signed a Joint Venture agreement with WSG Group in Busan, Korea, to establish a bioprocess solution joint venture in early 2021.

Preliminary results for the full year of 2020: Order intake up 49.0 percent; sales revenue up 30.2 percent; underlying EBITDA margin climbs to 29.6 percent

Through the esophagus, food enters the stomach and mixes with gastric acid, enzymes, and other gastric juices for digestion purpose.

An implantable port is a thin, soft, silicone tube with a small reservoir attached to it. It is generally put under the skin of chest or sometimes in arm.

Liquid-filled hard capsules refers to a technology that offers an advanced form of dosage in two different types, hydroxypropyl methyl cellulose and gelatin for multiparticulate, paste, semisolid, and liquid applications.

The drive for new technologies in duodenoscopes market is key to addressing diagnosis and treatment of severe, life-threatening diseases.